Retatroptide, agonis rangkap tiga dari Eli Lilly, secara signifikan memperbaiki berat badan, hemoglobin terglikasi A1C, nyeri osteoartritis lutut, dan apnea tidur obstruktif, menunjukkan potensi luar biasa dalam mengobati obesitas dan komplikasinya.
Indianapolis, 6 Juni 2026 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY), produsen Zepbound (tezapatide) dan Foundayo (ofofoglitazone), hari ini mengumumkan hasil positif lebih…
该文章暂未提取到完整正文，已从资讯列表和商品关联资讯中自动隐藏。你可以返回文章列表继续浏览其他内容。
Pertanyaan Umum
Which products are related to this article?
No strongly related product has been identified yet. The match updates automatically when the article or catalog changes.
How can I view the medicines discussed in this article?
Use the related product cards below the article to review available specifications, prices, product information, and reviews.
Does this article replace advice from a doctor or pharmacist?
No. This content is for general information and health education only. Follow the prescription and individual guidance provided by qualified healthcare professionals.
